Insider Actions for EyePoint Pharmaceuticals Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 09/04/2020 |
George O. Elston Chief Financial Officer |
10,000 | Acquisition at $0.48 per share. | 4,800 |
| 08/24/2020 |
George O. Elston Chief Financial Officer |
10,000 | Acquisition at $0.61 per share. | 6,100 |
| 06/30/2020 |
Nancy Sue Lurker President & CEO; Director |
124,667 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 06/30/2020 |
Dario A. Paggiarino Chief Medical Officer |
41,050 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 06/30/2020 |
Scott Jones SVP & Chief Commercial Officer |
41,050 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 06/30/2020 |
Dario A. Paggiarino Chief Medical Officer |
12,049 | Derivative/Non-derivative trans. at $0.76 per share. | 9,157 |
| 06/30/2020 |
Scott Jones SVP & Chief Commercial Officer |
14,060 | Derivative/Non-derivative trans. at $0.76 per share. | 10,685 |
| 06/27/2020 |
Nancy Sue Lurker President & CEO; Director |
40,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 06/27/2020 |
Dario A. Paggiarino Chief Medical Officer |
10,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 06/27/2020 |
Dario A. Paggiarino Chief Medical Officer |
2,936 | Derivative/Non-derivative trans. at $0.79 per share. | 2,319 |
| 06/14/2020 |
Nancy Sue Lurker President & CEO; Director |
45,000 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 06/14/2020 |
Dario A. Paggiarino Chief Medical Officer |
14,200 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 06/14/2020 |
Dario A. Paggiarino Chief Medical Officer |
4,168 | Derivative/Non-derivative trans. at $0.83 per share. | 3,459 |
| 03/12/2020 |
George O. Elston Chief Financial Officer |
10,000 | Acquisition at $0.96 per share. | 9,600 |
| 03/10/2020 |
Nancy Sue Lurker President & CEO; Director |
98,000 | Acquisition at $1.06 per share. | 103,880 |
| 02/21/2020 |
Nancy Sue Lurker President & CEO; Director |
137,174 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 11/15/2019 |
George O. Elston Chief Financial Officer |
10,000 | Acquisition at $1.43 per share. | 14,300 |
| 10/12/2019 |
Nancy Sue Lurker President & CEO; Director |
10,745 | Derivative/Non-derivative trans. at $2.1 per share. | 22,564 |
| 10/12/2019 |
Dario A. Paggiarino Chief Medical Officer |
2,450 | Derivative/Non-derivative trans. at $2.1 per share. | 5,145 |
